| Mr. Howard Donnelly |
Independent Non-Executive Chairman of the Board |
62 |
$262.0K - USD |
Male |
|
| Mr. James Clemmer |
President, Chief Executive Officer, Director |
59 |
$3.984M - USD |
Male |
|
| Mr. Stephen Trowbridge |
Chief Financial Officer, Executive Vice President |
49 |
$1.250M - USD |
Male |
|
| Mr. Chad Campbell |
Senior Vice President, General Manager - Vascular Access and Oncology |
52 |
$778.0K - USD |
Male |
|
| Mr. Scott Centea |
Senior Vice President, General Manager - Endovasular Therapies |
45 |
$841.4K - USD |
Male |
|
| Ms. Laura Piccinini |
Senior Vice President, General Manager - International |
54 |
$843.4K - USD |
Female |
|
| Ms. Eileen Auen |
Independent Director |
60 |
$224.5K - USD |
Female |
|
| Ms. Lorinda Burgess |
Independent Director |
61 |
- |
Female |
|
| Mr. Wesley Johnson |
Independent Director |
65 |
$234.5K - USD |
Male |
|
| Ms. Karen Licitra |
Independent Director |
64 |
$224.5K - USD |
Female |
|
| Ms. Jan Reed |
Independent Director |
63 |
$224.5K - USD |
Female |
|
| Dr. Michael Tarnoff |
Independent Director |
55 |
$214.5K - USD |
Male |
|
